Opioid Use Disorder Market Size, Share, Analysis, Trends, Growth Report, 2030
Opioid Use Disorder Industry Perspective:
The global Opioid Use Disorder market size was evaluated at $1500.39 Million in 2018 and is slated to hit $2853.57? million by the end of 2030 with a CAGR of nearly 9.69% between 2019 and 2025.
Get a Free Sample : https://www.zionmarketresearch.com/sample/opioid-use-disorder-market
The report covers forecast and analysis for the Opioid Use Disorder market on a global and regional level. The study provides historic data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the Opioid Use Disorder market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Opioid Use Disorder market on a global level. In order to give the users of this report a comprehensive view of the Opioid Use Disorder market we have included a competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein Drug and regional segments are benchmarked based on their market size, growth rate, and general attractiveness.
Opioids, used for pain relief medicinally, have depressing effects on the analgesic and central nervous system as well as the potential for euphoria. Opioid use disorder (OUD) may include misuse of prescribed opioid drugs, use of diverted opioid drugs, or use of unlawfully obtained heroin. Opioid use disorder is typically a chronic, recurrent disease associated with significantly higher morbidity and mortality rates.
Opioid Use Disorder Market: Growth Factors
The growing number of patients suffering from opioid-related addiction, rising government initiatives, and increasing support from NGOs and agencies are key factors driving the market for disorder treatment for opioid use. With the help of government agencies and many others, the NGOs coordinate various programs and campaigns to increase awareness of the clinical ill effects of Opioid abuse.
These programs are aimed at eradicating illicit drug use in federal workplaces and contributing to drug-free all workplaces. However, individuals ' reluctance to access treatment modalities and the discontinuation of behavioral therapies that lead to relapse are the factors that restrict this market's growth. Crucial opportunities for this market are government initiatives and funding.
Directly Purchase a copy of the report with TOC : https://www.zionmarketresearch.com/toc/opioid-use-disorder-market
Opioid Use Disorder Market: Segmentation
The study provides a decisive view of the Opioid Use Disorder market by segmenting the market based on Product, End-user, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. Based on Drugs, the market is segmented into Buprenorphine, Methadone, and Naltrexone. Buprenorphine is further classified into Bunavail, Sublocade, Suboxone, Zubsolv, and Others. The largest revenue-generating segment in 2018 was buprenorphine.
The most widely prescribed drugs for opioid use disorder include buprenorphine/naloxone sublingual tablets, branded suboxone, and buprenorphine sublingual tablets. Because of its excellent clinical profile, Suboxone Film is the most prescribed drug on the opioid use disorder market. High effectiveness in addiction treatment, low potential for abuse & relatively slight adverse effects, and favorable type exposure are factors that can be contributed to this drug's high acceptance.
The geographical segmentation comprises the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America was the biggest revenue-generating market in 2018 and over the forecast period is expected to show the same pattern. The U.S. and Canada's opioid epidemic is one of the major contributing factors to North America's largest market share. Governments are implementing a number of policies to manage the crisis.
Opioid Use Disorder Market: Competitive Space
Key players within the global Opioid Use Disorder market include
- Indivior
- Alkermes
- Titan Pharmaceuticals
- Hikma Pharmaceuticals
- Teva Pharmaceuticals
- MediciNova
- Orexo
- Camurus
- Omeros
- amongst others.
The report segments the global Opioid Use Disorder market as follows:
Global Opioid Use Disorder Market: Drug Segment Analysis
- Buprenorphine
- Bunavail
- Sublocade
- Suboxone
- Zubsolv
- Others
- Methadone
- Naltrexone
Global Opioid Use Disorder Market: Regional Segment Analysis
- North America
- U.S.
- Europe
- UK
- France
- Germany
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- Middle East and Africa
Comments
Post a Comment